She, J., Chen, X., Iyengar, M., & Li, J. (2026). Evaluation of Minimal Residual Disease as a Surrogate for Progression-Free Survival in Hematology Oncology Trials: A Meta-Analytic Review.
Citazione stile Chigago Style (17a edizione)She, Jane, Xiaofei Chen, Malini Iyengar, e Judy Li. Evaluation of Minimal Residual Disease as a Surrogate for Progression-Free Survival in Hematology Oncology Trials: A Meta-Analytic Review. 2026.
Citatione MLA (9a ed.)She, Jane, et al. Evaluation of Minimal Residual Disease as a Surrogate for Progression-Free Survival in Hematology Oncology Trials: A Meta-Analytic Review. 2026.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.